| Neal Robert Swerdlow, MD, PHD | |
|
9500 Gilman Dr., Ucsd Department Of Psychiatry, 0804, La Jolla, CA 92093-0804 | |
| (619) 543-6270 | |
| Not Available |
| Full Name | Neal Robert Swerdlow |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 9500 Gilman Dr., La Jolla, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134476344 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | G62289 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Neal Robert Swerdlow, MD, PHD 9500 Gilman Dr., Ucsd Department Of Psychiatry, 0804, La Jolla, CA 92093-0804 Ph: (619) 543-6270 | Neal Robert Swerdlow, MD, PHD 9500 Gilman Dr., Ucsd Department Of Psychiatry, 0804, La Jolla, CA 92093-0804 Ph: (619) 543-6270 |
News Archive
Absorption Systems, a leader in drug safety and ADMET (absorption, distribution, metabolism, excretion and toxicity) testing, today announced the introduction of a more complete series of drug metabolism assays designed to support the pharmaceutical R&D process, from early-stage discovery through late-stage clinical development.
Researchers from Mount Sinai School of Medicine have for the first time determined that the ketogenic diet, a specialized high-fat, low carbohydrate diet, may reverse impaired kidney function in people with Type 1 and Type 2 diabetes. They also identified a previously unreported panel of genes associated with diabetes-related kidney failure, whose expression was reversed by the diet. The findings were published in the current issue of PLoS ONE.
The report by the Public Health Association of Australia (PHAA) says that the only way to effectively address the priorities of chronic disease prevention, climate change and social inequality is by a complete overhaul of food policy in Australia.
Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements.
› Verified 9 days ago
Dr. Hohui Wang, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9500 Gilman Dr # 9116a, La Jolla, CA 92093 Phone: 858-534-4040 Fax: 848-822-0231 | |
Dr. Elizabeth Ann Bevins, MD, PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Uc San Diego Center For Brain Health, 9444 Medical Center Dr, La Jolla, CA 92037 Phone: 858-657-8540 | |
Abigail Clark, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9500 Gilman Dr # 9116a, La Jolla, CA 92093 Phone: 619-471-0259 | |
Dr. Jody Corey-bloom, MD, PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8950 Villa La Jolla Dr, C129, La Jolla, CA 92037 Phone: 858-246-1288 Fax: 858-246-1283 | |
Dr. David Feifel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3252 Holiday Ct Ste 112, La Jolla, CA 92037 Phone: 858-412-4130 Fax: 858-412-5088 | |
Dr. Abraham S.c. Chyung, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8676 | |
Mary Margaret Ewing, M.D., M.B.A. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1120 Silverado St Ste 203, La Jolla, CA 92037 Phone: 858-412-5141 |